Shannon K, Ishida T, Morgan R, Bear A, Oleson M, Kerr T, Tyndall MW Potential community and public health impacts of medically supervised safer smoking facilities for crack cocaine users Harm Reduction Journal, 2006. PubMed


Kuyper LM, Kerr T, Li K, Hogg RS, Tyndall MW, Montaner JS, Wood E Factors associated with buying and selling syringes among injection drug users in a setting of one of North America's largest syringe exchange programs Substance Use & Misuse, 2006. PubMed


Miller CL, Kerr T, Frankish J, Spittal P, Li K, Schechter MT, Wood E Binge drug use independently predicts HIV seroconversion among injection drug users: implications for public health strategies Substance Use & Misuse, 2006. PubMed


Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW Prevalence and correlates of hepatitis C infection among users of North America’s first medically supervised safer injection facility Public Health, 2005. PubMed


Small W, Wood E, Jürgens R, Kerr T Injection drug use, HIV/AIDS and incarceration: evidence from the Vancouver Injection Drug Users Study HIV/AIDS Policy & Law Review, 2005. PubMed


O'Connell JM, Kerr T, Li K, Tyndall MW, Hogg RS, Montaner JS, Wood E Requiring help injecting independently predicts incident HIV infection among injection drug users Journal of Acquired Immune Deficiency Syndromes, 2005. PubMed


Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T Do supervised injecting facilities attract higher-risk injection drug users? American Journal of Preventive Medicine, 2005. PubMed


Kerr T, Tyndall M, Li K, Montaner J, Wood E Safer injection facility use and syringe sharing in injection drug users The Lancet, 2005. PubMed


Shannon K, Kerr T, Lai C, Ishida T, Wood E, Montaner JSG, Hogg RS, Tyndall MW Nonadherence to antiretroviral therapy among a community with endemic rates of injection drug use Journal of the International Association of Physicians in AIDS Care, 2005. PubMed


Kerr T, Marshall A, Walsh J, Palepu A, Tyndall M, Montaner J, Hogg R, Wood E Determinants of HAART discontinuation among injection drug users AIDS Care, 2005. PubMed


BC Centre on Substance Use
400-1045 Howe St, Vancouver, BC V6Z 2A9

E: [email protected] | T: (778) 945-7616 | F: (604) 428-5183

24/7 Addiction Clinician Support Line: (778) 945-7619

ACTOC and POATSP: [email protected]




Copyright © 2023, BC Centre on Substance Use